35949576|t|Ventricular assist device implantation in a patient with systemic right ventricle and pectus excavatum.
35949576|a|Systemic right ventricular failure is a common finding in patients with transposition of the great arteries. Some of these patients require ventricular assist device implantation. We describe the feasibility of HeartMate 3 [Abbott, Illinois, United States] implantation in a patient with transposition of the great arteries, high human leukocyte antigen sensitization, and severe pectus excavatum using a two-stage approach. Learning objectives: 1.To notice the challenges faced while implanting HeartMate 3 [Abbott, Illinois, United States] in patients with congenital heart disease and anatomical limitations.2.To understand that despite the difficulties, HeartMate 3 implantation is possible, worthwhile, and sometimes the only choice in a patient with end-stage heart failure and congenital heart disease.
35949576	44	51	patient	Species	9606
35949576	57	81	systemic right ventricle	Disease	MESH:C535682
35949576	86	102	pectus excavatum	Disease	MESH:D005660
35949576	113	138	right ventricular failure	Disease	MESH:D051437
35949576	162	170	patients	Species	9606
35949576	176	211	transposition of the great arteries	Disease	MESH:D014188
35949576	227	235	patients	Species	9606
35949576	315	326	HeartMate 3	Chemical	-
35949576	379	386	patient	Species	9606
35949576	392	427	transposition of the great arteries	Disease	MESH:D014188
35949576	434	439	human	Species	9606
35949576	484	500	pectus excavatum	Disease	MESH:D005660
35949576	600	611	HeartMate 3	Chemical	-
35949576	649	657	patients	Species	9606
35949576	663	687	congenital heart disease	Disease	MESH:D006330
35949576	762	773	HeartMate 3	Chemical	-
35949576	847	854	patient	Species	9606
35949576	870	883	heart failure	Disease	MESH:D006333
35949576	888	912	congenital heart disease	Disease	MESH:D006330

